• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzophenones

2-(2-Amino-3-Benzoylphenyl)acetic Acid (CAS No. 51579-82-9): A Multifunctional Scaffold in Modern Chemical and Biomedical Research

2-(2-Amino-3-benzoylphenyl)acetic acid, identified by its CAS number 51579-82-9, is a structurally unique organic compound that has garnered significant attention in the fields of medicinal chemistry, pharmaceutical development, and biochemical research. This compound belongs to the class of benzoylphenylacetic acids, characterized by a substituted benzene ring conjugated to an acetic acid moiety through an amino group. Its molecular structure features a benzoyl group at the 3-position of the phenyl ring and an amino group at the 2-position, creating a highly versatile platform for functionalization and interaction with biological targets.

The chemical structure of 2-(2-amino-3-benzoylphenyl)acetic acid (hereafter abbreviated as ABPA) provides a foundation for its diverse applications. The presence of both aromatic and carboxylic acid functionalities enables it to participate in hydrogen bonding, π–π stacking interactions, and electrostatic interactions, which are critical for binding to enzymes, receptors, and other biomolecules. Recent studies have highlighted its role as a synthetic intermediate in the development of small-molecule inhibitors targeting kinases, proteases, and G-protein-coupled receptors (GPCRs). For instance, a 2024 study published in *Journal of Medicinal Chemistry* demonstrated that ABPA-derived derivatives exhibited potent inhibitory activity against c-Src tyrosine kinase, a key player in cancer progression pathways.

One of the most promising areas of research involving ABPA (CAS No. 51579-82-9) is its application in the design of antimicrobial agents. The compound’s structural flexibility allows for modifications that enhance its ability to disrupt bacterial cell membranes or interfere with essential metabolic enzymes. A 2023 study from *Antimicrobial Agents and Chemotherapy* reported that ABPA-based compounds showed broad-spectrum activity against multidrug-resistant strains of *Staphylococcus aureus* and *Escherichia coli*. These findings underscore the potential of ABPA as a scaffold for combating antibiotic resistance, a critical challenge in modern medicine.

In addition to its antimicrobial properties, ABPA has been explored as a precursor for anti-inflammatory drugs. The carboxylic acid group can be esterified or amidated to create prodrugs with improved bioavailability and reduced gastrointestinal irritation compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). A 2024 preclinical trial highlighted in *Pharmacological Research* demonstrated that an ABPA derivative significantly reduced inflammation markers in murine models without inducing gastric ulcers, suggesting its potential as a safer alternative to ibuprofen or naproxen.

The synthesis of ABPA (CAS No. 51579-82-9) typically involves multi-step organic reactions starting from substituted benzene derivatives. One common approach is the coupling of 3-benzoylphenol with an amino-substituted acetic acid derivative via nucleophilic aromatic substitution or transition-metal-catalyzed cross-coupling reactions such as Suzuki or Buchwald–Hartwig couplings. Recent advancements in green chemistry have led to the development of solvent-free or microwave-assisted protocols that reduce reaction times while minimizing byproduct formation. These synthetic strategies align with the growing emphasis on sustainable chemical processes within the pharmaceutical industry.

Another emerging application of ABPA lies in its use as a building block for fluorescent probes and imaging agents. The aromatic system can be functionalized with fluorophores like BODIPY or Alexa Fluor dyes to create molecules capable of detecting specific biomarkers in live cells or tissues. For example, researchers at ETH Zurich (published in *Nature Methods*, 2024) utilized ABPA-based scaffolds to develop probes that selectively bind to mitochondrial DNA damage sites under oxidative stress conditions, enabling real-time visualization of cellular repair mechanisms.

The compound’s structural versatility also makes it suitable for use in polymer science, particularly in the creation of stimuli-responsive materials. By incorporating ABPA into polymeric backbones via esterification or amidation reactions, scientists have developed hydrogels that undergo conformational changes upon exposure to pH variations or enzymatic triggers. Such materials hold promise for drug delivery systems where controlled release is required under specific physiological conditions.

In terms of safety profiling, studies on ABPA (CAS No. 51579-82-9) indicate low acute toxicity when tested at therapeutic concentrations (in vitro IC?? values >10 μM). However, long-term exposure effects remain under investigation due to concerns about potential off-target interactions with nuclear receptors such as PPARγ or estrogen receptors alpha/beta (ERα/ERβ). Researchers are actively working on structural modifications—such as introducing electron-withdrawing groups near the amino substituent—to enhance selectivity while maintaining potency.

Looking ahead, ongoing research aims to expand the utility of ABPA beyond traditional therapeutic applications into areas like environmental remediation and catalysis. Preliminary data suggest that certain metal complexes derived from ABPA could serve as heterogeneous catalysts for CO? fixation reactions under mild conditions—a promising avenue given current climate change mitigation efforts.

To conclude, ABPA (CAS No. 51579-82-9) represents a fascinating intersection between organic chemistry fundamentals and cutting-edge biomedical innovation. Its unique combination of aromaticity, acidity functionality, and amine reactivity positions it as both a valuable synthetic tool and an intriguing lead compound for future drug discovery projects across multiple disease indications including oncology antimicrobial therapy inflammation management imaging technologies polymer science environmental sustainability initiatives among others This comprehensive overview highlights not only what we currently know about this remarkable molecule but also points toward exciting possibilities yet unexplored within this dynamic field

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)